drugset / Trial / NCT00735020

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

NCT00735020

Phase 1 Completed 72 enrolled Novartis Vaccines
RandomizedParallel-groupSingle-blindPrevention

Summary

This trial is designed to evaluate safety, tolerability and immunogenicity of a bedside mixing formulation of adjuvanted influenza vaccines.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluad Vaccine
Comparator Influenza Virus Vaccine Vaccine

Indications